Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC

(RARE)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Latest news on ULTRAGENYX PHARMACEUTICAL
02/21ULTRAGENYX PHARMACEUTICAL INC. : Other Events, Financial Statements and Exhibits..
AQ
02/21ULTRAGENYX PHARMACEUTICAL : Announces Positive 24-week Data from First Cohort of..
AQ
02/20ULTRAGENYX PHARMACEUTICAL : Management's Discussion and Analysis of Financial Co..
AQ
02/19ULTRAGENYX : 4Q Earnings Snapshot
AQ
02/19ULTRAGENYX PHARMACEUTICAL INC. : Results of Operations and Financial Condition, ..
AQ
02/19Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Co..
GL
02/16Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita (bu..
AQ
02/15Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita fro..
AQ
02/14ULTRAGENYX PHARMACEUTICAL : and Kyowa Kirin Announce Positive 64-Week Results fo..
AQ
02/12ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for Fourth Quarter and Full-..
PU
02/12ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for Fourth Quarter and Full-..
AQ
02/04ULTRAGENYX PHARMACEUTICAL INC. : Change in Directors or Principal Officers (form..
AQ
02/04Ultragenyx Appoints Shehnaaz Suliman, M.D., to Board of Directors
GL
01/22ULTRAGENYX PHARMACEUTICAL : Announces Positive Topline Data from Ongoing Long-Te..
AQ
01/15ULTRAGENYX PHARMACEUTICAL INC. : Entry into a Material Definitive Agreement (for..
AQ
01/07ULTRAGENYX PHARMACEUTICAL INC. : Regulation FD Disclosure, Other Events, Financi..
AQ
01/07Flurry of management moves on eve of JPM
AQ
01/05ULTRAGENYX PHARMACEUTICAL : Announces Positive Topline Results from First Cohort..
AQ
01/04Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 ..
GL
01/03Ultragenyx to Present at J.P. Morgan Healthcare Conference
GL
2018Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita (buros..
AQ
2018Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™..
GL
2018ULTRAGENYX PHARMACEUTICAL : Announces Intent to Submit New Drug Application to U..
AQ
2018ULTRAGENYX PHARMACEUTICAL INC. : Other Events, Financial Statements and Exhibits..
AQ
2018ULTRAGENYX PHARMACEUTICAL : Announces Intent to Submit New Drug Application to U..
AQ
2018ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
2018ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
2018ULTRAGENYX PHARMACEUTICAL : Management's Discussion and Analysis of Financial Co..
AQ
2018ULTRAGENYX PHARMACEUTICAL INC. : Results of Operations and Financial Condition, ..
AQ
2018ULTRAGENYX : 3Q Earnings Snapshot
AQ
2018Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update
GL
2018Lilly buys Siga's Priority Review voucher gained via smallpox approval
AQ
2018Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results a..
GL
2018ULTRAGENYX PHARMACEUTICAL : Announces Negative Topline Results from Phase 3 Stud..
AQ
2018ULTRAGENYX PHARMACEUTICAL : UX007 fails Phase III in glucose transporter disorde..
AQ
2018Ultragenyx Announces Negative Topline Results from Phase 3 Study of UX007 in ..
GL
2018ULTRAGENYX PHARMACEUTICAL : Announces Exclusive License to REGENXBIO AAV Vectors..
AQ
2018ULTRAGENYX PHARMACEUTICAL : Announces Exclusive License to REGENXBIO AAV Vectors..
AQ
2018Ultragenyx Announces Exclusive License to REGENXBIO AAV Vectors to Develop Ge..
GL
2018ULTRAGENYX PHARMACEUTICAL : Announces Approval of Mepsevii in Brazil for the Tre..
AQ
2018Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Brazi..
GL
2018FDA, EMA to review Novartis' siponimod for secondary progressive MS
AQ
2018ULTRAGENYX PHARMACEUTICAL : to Present at Jefferies Gene Therapy Summit
AQ
2018ULTRAGENYX PHARMACEUTICAL : to Present at Jefferies Gene Therapy Summit
AQ
2018Ultragenyx Announces Positive Topline Cohort 2 Results from Phase 1/2 Clinica..
GL
2018ULTRAGENYX PHARMACEUTICAL : to Present at Jefferies Gene Therapy Summit
AQ
2018ULTRAGENYX PHARMACEUTICAL : Expands Leadership Team and Appoints Dr. Wladimir Ho..
AQ
2018ULTRAGENYX PHARMACEUTICAL : appoints Dr. Wladimir Hogenhuis as COO
AQ
2018ULTRAGENYX PHARMACEUTICAL INC. : Change in Directors or Principal Officers, Fina..
AQ
2018Ultragenyx Expands Leadership Team and Appoints Dr. Wladimir Hogenhuis as Chi..
GL
2018Ultragenyx to Present at Upcoming Investor Conferences
GL
2018ULTRAGENYX PHARMACEUTICAL : FDA clarifies path to submission for Ultragenyx's ra..
AQ
2018ULTRAGENYX PHARMACEUTICAL INC. : Other Events, Financial Statements and Exhibits..
AQ
2018ULTRAGENYX PHARMACEUTICAL : Announces FDA Accepts Proposal to Submit an NDA for ..
AQ
2018ULTRAGENYX PHARMACEUTICAL : Announces Approval of Mepsevii in Europe for the Tre..
AQ
2018ULTRAGENYX PHARMACEUTICAL : Announces Approval of Mepsevii (vestronidase alfa) i..
AQ
2018Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Europ..
GL
2018ULTRAGENYX PHARMACEUTICAL INC. : Temporary Suspension of Trading Under Registran..
AQ
2018ULTRAGENYX PHARMACEUTICAL : Management's Discussion and Analysis of Financial Co..
AQ
2018ULTRAGENYX PHARMACEUTICAL INC. : Regulation FD Disclosure, Financial Statements ..
AQ
2018ULTRAGENYX : 2Q Earnings Snapshot
AQ
2018ULTRAGENYX PHARMACEUTICAL INC. : Results of Operations and Financial Condition, ..
AQ
2018Ultragenyx Reports Second Quarter 2018 Financial Results and Corporate Update
GL
2018ULTRAGENYX PHARMACEUTICAL : to Host Conference Call for Second Quarter 2018 Fina..
AQ
2018ULTRAGENYX PHARMACEUTICAL : doses first patient in DTX401 Phase 1/2 study to tre..
AQ
2018ULTRAGENYX PHARMACEUTICAL : Announces First Patient Dosed in Phase 1/2 study of ..
AQ
2018Ultragenyx to Host Conference Call for Second Quarter 2018 Financial Results ..
GL
2018ULTRAGENYX PHARMACEUTICAL : Announces First Patient Dosed in Phase 1/2 study of ..
AQ
2018ULTRAGENYX PHARMACEUTICAL : Announces Positive CHMP Opinion for Mepsevii for the..
AQ
2018CHMP backs CAR Ts, Orphan candidates
AQ
2018Ultragenyx Announces Positive CHMP Opinion for Mepsevii™ (vestronidase ..
GL
2018ULTRAGENYX PHARMACEUTICAL INC. : Submission of Matters to a Vote of Security Hol..
AQ
2018ULTRAGENYX PHARMACEUTICAL INC. : Change in Directors or Principal Officers (form..
AQ
2018ULTRAGENYX PHARMACEUTICAL : to Present at Upcoming Investor Conferences
AQ
2018Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demo..
AQ
1  2  3  4Next
Upcoming event on ULTRAGENYX PHARMACEUTICAL